By www.marketscagr.com
Global And Japan Progressive Supranuclear Palsy Market Size, Status And Forecast 2024-2031 Story
108
$ 3900
Progressive Supranuclear Palsy Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Merck & Co., Inc.
Aton Pharma, Inc.
Bristol Myers Squibb (BMS)
GlaxoSmithKline plc
Novartis AG
Teva Pharmaceutical Industries Ltd.
AB Science
AbbVie Inc.
AlzProtect SAS
Cortice Biosciences, Inc.
Acorda Therapeutics Inc.
Biogen Inc.